| Literature DB >> 28655298 |
Yodit Ayele1, Fanta Desissa Gutema2, Bedaso Mamo Edao1, Robel Girma1, Takele Beyene Tufa3, Tariku Jibat Beyene4, Fanos Tadesse3, Mesula Geloye1, Ashenafi Feyisa Beyi3.
Abstract
BACKGROUND: Staphylococcus aureus is one of the leading causes of gastroenteritis acquired from contaminated foods such as milk and milk products. However, such information is limited in Ethiopia. A cross-sectional study was conducted to assess the contamination of milk with S. aureus and knowledge, attitudes and practices (KAP) of actors along the milk value chain in Sebeta, Central Oromia, Ethiopia. A total of 291 samples collected from dairy farms, milk collection centers (MCCs) and processing plant were examined using standard microbiological techniques. The antimicrobial susceptibility profiles of the isolates were also investigated. The KAP of actors in milk value chain were evaluated through a structured questionnaire.Entities:
Keywords: And staphylococcal food poisoning; Antimicrobial resistance; Dairy farms; Milk borne diseases; Milk value chain; Raw milk consumption; S. aureus
Mesh:
Substances:
Year: 2017 PMID: 28655298 PMCID: PMC5488358 DOI: 10.1186/s12866-017-1048-9
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Prevalence of S. aureus in four milk collection centers in Sebeta, central Oromia, Ethiopia
| Milk collection centers | No. of examined samples | No. of positive samples (%) |
|
|---|---|---|---|
| Center 2 | 4 | 2 (50) | <0.05 |
| Center 3 | 3 | 3 (100) | |
| Center 5 | 6 | 4 (66.7) | |
| Center 7 | 7 | 7 (100) | |
| Total | 20 | 16 (80) |
Antimicrobial susceptibility profile of S. aureus isolates according to the types of samples
| Antimicrobial | Unit | Type of samples susceptible to different antimicrobial agents | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Farm milk ( | Milker’s Hand swabs ( | Milking bucket swab ( | MCCs ( | ||||||||||
| R | I | S | R | I | S | R | I | S | R | I | S | ||
| Ciprofloxacin | 5 μg | 3 (7.3) | 5 (12.2) | 33 (80.5) | 4 (50) | 0 (0.0) | 4 (50) | 0 (0.0) | 0 (0.0) | 3 (100) | 0 (0.0) | 0 (0.0) | 16 (100) |
| Nalidixic acid | 30 μg | 8 (19.5) | 23 (56.1) | 10 (24.4) | 2 (25) | 0 (0.0) | 6 (75) | 0 (0.0) | 2 (66.7) | 1 (33.3) | 2 (12.5) | 2 (12.5) | 12 (75) |
| Vancomycin | 30 μg | 26 (63.4) | 0 (0.0) | 15 (36.6) | 4 (50) | 0 (0.0) | 4 (50) | 2 (66.7) | 0 (0.0) | 1 (33.3) | 12 (75) | 0 (0.0) | 4 (25) |
| Penicillin G | 10 units | 41 (100) | 0 (0.0) | 0 (0.0) | 8 (100) | 0 (0.0) | 0 (0.0) | 2 (66.7) | 0 (0.0) | 1 (33.3) | 16 (100) | 0 (0.0) | 0 (0.0) |
| Amoxicillin | 30 μg | 25 (60.9) | 8 (19.5) | 8 (19.5) | 8 (100) | 0 (0.0) | 0 (0.0) | 2 (66.7) | 1 (33.3) | 0 (0.0) | 12 (75) | 2 (12.5) | 2 (12.5) |
| Cefoxitin | 30 μg | 41 (100) | 0 (0.0) | 0 (0.0) | 8 (100) | 0 (0.0) | 0 (0.0) | 3 (100) | 0 (0.0) | 0 (0.0) | 16 (100) | 0 (0.0) | 0 (0.0) |
| Streptomycin | 10 μg | 36 (87.8) | 0 (0.0) | 5 (12.2) | 4 (50) | 4 (50) | 0 (0.0) | 3 (100) | 0 (0.0) | 0 (0.0) | 10 (62.5) | 0 (0.0) | 6 (37.5) |
| Erythromycin | 15 μg | 28 (68.3) | 5 (12.2) | 8 (19.5) | 4 (50) | 0 (0.0) | 4 (50) | 3 (100) | 0 (0.0) | 0 (0.0) | 12 (75) | 2 (12.5) | 2 (12.5) |
| SXT | 25 μg | 15 (36.6) | 0 (0.0) | 26 (63.4) | 4 (50) | 0 (0.0) | 4 (50) | 1 (33.3) | 0 (0.0) | 2 (66.7) | 2 (12.5) | 0 (0.0) | 14 (12.5) |
| Tetracycline | 30 μg | 28 (68.3) | 0 (0.0) | 13 (31.7) | 8 (100) | 0 (0.0) | 0 (0.0) | 2 (66.7) | 0 (0.0) | 1 (33.3) | 6 (37.5) | 0 (0.0) | 10 (62.5) |
Key: I Intermediate, MCCs Milk collection centers, n number of S. aureus isolated, No number of S. aureus showing resistance, intermediate or susceptible to antimicrobials tested, R Resistant, S Susceptible, SXT Sulphamethoxazole-Trimethoprim